Oxidative folding and structural analyses of a Kunitz-related inhibitor and its disulfide intermediates: functional implications.
暂无分享,去创建一个
Francesc X Aviles | David Pantoja-Uceda | F. Avilés | D. Pantoja-Uceda | Sílvia Bronsoms | J. Santoro | J. Arolas | Joan L Arolas | C. Sommerhoff | Christian P Sommerhoff | Jorge Santoro | Sílvia Bronsoms | Dusica Gabrijelcic-Geiger | Laura Sanglas | L. Sanglas | D. Gabrijelcic‐Geiger | Laura Sanglas
[1] K. Wüthrich. NMR of proteins and nucleic acids , 1988 .
[2] H. Scheraga,et al. Structural characterization of an analog of the major rate-determining disulfide folding intermediate of bovine pancreatic ribonuclease A. , 1997, Biochemistry.
[3] P. S. Kim,et al. Reexamination of the folding of BPTI: predominance of native intermediates , 1991, Science.
[4] J. Otlewski,et al. The many faces of protease–protein inhibitor interaction , 2005, The EMBO journal.
[5] Robert F Gahl,et al. Oxidative folding pathway of onconase, a ribonuclease homologue: insight into oxidative folding mechanisms from a study of two homologues. , 2009, Biochemistry.
[6] W. Bode,et al. The structure of the human betaII-tryptase tetramer: fo(u)r better or worse. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[7] K. Wüthrich,et al. Structure and internal dynamics of the bovine pancreatic trypsin inhibitor in aqueous solution from long‐time molecular dynamics simulations , 1995, Proteins.
[8] Paolo Ascenzi,et al. The bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor): a milestone protein. , 2003, Current protein & peptide science.
[9] M. Billeter,et al. MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.
[10] K Wüthrich,et al. NMR solution structure of the recombinant tick anticoagulant protein (rTAP), a factor Xa inhibitor from the tick Ornithodoros moubata , 1994, FEBS letters.
[11] S. Macedo-Ribeiro,et al. Tick-derived Kunitz-type inhibitors as antihemostatic factors. , 2009, Insect biochemistry and molecular biology.
[12] J F Morrison,et al. Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors. , 1969, Biochimica et biophysica acta.
[13] H. Scheraga,et al. Regeneration of bovine pancreatic ribonuclease A: identification of two nativelike three-disulfide intermediates involved in separate pathways. , 1998, Biochemistry.
[14] Jui-Yoa Chang,et al. Structure and Heterogeneity of the One- and Two-Disulfide Folding Intermediates of Tick Anticoagulant Peptide , 2000, Journal of protein chemistry.
[15] T. Creighton,et al. On the biosynthesis of bovine pancreatic trypsin inhibitor (BPTI). Structure, processing, folding and disulphide bond formation of the precursor in vitro and in microsomes. , 1993, Journal of molecular biology.
[16] R. Huber,et al. Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. , 1998, Nature.
[17] T. Creighton,et al. Refolding of bovine pancreatic trypsin inhibitor via non-native disulphide intermediates. , 1995, Journal of molecular biology.
[18] H. Scheraga,et al. Regeneration of bovine pancreatic ribonuclease A: detailed kinetic analysis of two independent folding pathways. , 1998, Biochemistry.
[19] C. Sommerhoff. Mast cell tryptases and airway remodeling. , 2001, American journal of respiratory and critical care medicine.
[20] F. Avilés,et al. Deciphering the Structural Basis That Guides the Oxidative Folding of Leech-derived Tryptase Inhibitor* , 2009, The Journal of Biological Chemistry.
[21] A. Mark,et al. The structure of a two-disulfide intermediate assists in elucidating the oxidative folding pathway of a cyclic cystine knot protein. , 2008, Structure.
[22] H. Scheraga,et al. Kinetic folding pathway of a three-disulfide mutant of bovine pancreatic ribonuclease A missing the [40-95] disulfide bond. , 1998, Biochemistry.
[23] F. Avilés,et al. Oxidative folding of leech-derived tryptase inhibitor via native disulfide-bonded intermediates. , 2008, Antioxidants & redox signaling.
[24] J. Chang. The disulfide folding pathway of tick anticoagulant peptide (TAP), a Kunitz-type inhibitor structurally homologous to BPTI. , 1996, Biochemistry.
[25] Mohammad M. Islam,et al. Crystal structure of an extensively simplified variant of bovine pancreatic trypsin inhibitor in which over one-third of the residues are alanines , 2008, Proceedings of the National Academy of Sciences.
[26] Jui-Yoa Chang,et al. Diverse pathways of oxidative folding of disulfide proteins: underlying causes and folding models. , 2011, Biochemistry.
[27] M. Qasim,et al. What can the structures of enzyme-inhibitor complexes tell us about the structures of enzyme substrate complexes? , 2000, Biochimica et biophysica acta.
[28] Hilla Peretz,et al. Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .
[29] J. Bieth. Pathophysiological interpretation of kinetic constants of protease inhibitors. , 1980, Bulletin europeen de physiopathologie respiratoire.
[30] G. Pejler,et al. Biology of mast cell tryptase , 2006 .
[31] R. Huber,et al. The Three-dimensional Structure of Recombinant Leech-derived Tryptase Inhibitor in Complex with Trypsin , 1997, The Journal of Biological Chemistry.
[32] David I Stuart,et al. A tick protein with a modified Kunitz fold inhibits human tryptase. , 2007, Journal of molecular biology.
[33] R. Huber,et al. Human β-tryptase is a ring-like tetramer with active sites facing a central pore , 1998, Nature.
[34] M. Karplus,et al. A conformational isomer of bovine pancreatic trypsin inhibitor protein produced by refolding , 1980, Nature.
[35] N. Rawlings. Peptidase inhibitors in the MEROPS database. , 2010, Biochimie.
[36] Harold A. Scheraga,et al. Mechanism of reductive protein unfolding , 1995, Nature Structural Biology.
[37] H. Scheraga,et al. Regeneration of three-disulfide mutants of bovine pancreatic ribonuclease A missing the 65-72 disulfide bond: characterization of a minor folding pathway of ribonuclease A and kinetic roles of Cys65 and Cys72. , 1998, Biochemistry.
[38] G. Pejler,et al. Biology of mast cell tryptase. An inflammatory mediator. , 2006, The FEBS journal.
[39] G. Fendrich,et al. Purification, characterization and biological evaluation of recombinant leech-derived tryptase inhibitor (rLDTI) expressed at high level in the yeast Saccharomyces cerevisiae. , 1996, European journal of biochemistry.
[40] H. Scheraga,et al. Disulfide bonds and protein folding. , 2000, Biochemistry.
[41] P. Güntert. Automated NMR structure calculation with CYANA. , 2004, Methods in molecular biology.
[42] F. Avilés,et al. Designing out disulfide bonds of leech carboxypeptidase inhibitor: implications for its folding, stability and function. , 2009, Journal of molecular biology.
[43] C. Sommerhoff,et al. Mast cell tryptase beta as a target in allergic inflammation: an evolving story. , 2007, Current pharmaceutical design.
[44] E. Auerswald,et al. A Kazal-type inhibitor of human mast cell tryptase: isolation from the medical leech Hirudo medicinalis, characterization, and sequence analysis. , 1994, Biological chemistry Hoppe-Seyler.
[45] M. Laskowski,et al. THE BASIC TRYPSIN INHIBITOR OF BOVINE PANCREAS. IV. THE LINEAR SEQUENCE OF THE 58 AMINO ACIDS. , 1965, Biochemical and biophysical research communications.
[46] M. Laskowski,et al. The basic trypsin inhibitor of bovine pancreas. V. The disulfide linkages. , 1965, Biochemical and biophysical research communications.
[47] W. Bode,et al. The human mast cell tryptase tetramer: a fascinating riddle solved by structure. , 2000, Biochimica et biophysica acta.
[48] Jui-Yoa Chang,et al. The structure of denatured bovine pancreatic trypsin inhibitor (BPTI) , 2000, FEBS letters.
[49] Jui-Yoa Chang. Distinct folding pathways of two homologous disulfide proteins: bovine pancreatic trypsin inhibitor and tick anticoagulant peptide. , 2011, Antioxidants & redox signaling.
[50] H. Scheraga,et al. Structural determinants of oxidative folding in proteins , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[51] T. Holak,et al. NMR structural characterization and computational predictions of the major intermediate in oxidative folding of leech carboxypeptidase inhibitor. , 2005, Structure.
[52] F. Avilés,et al. Role of Kinetic Intermediates in the Folding of Leech Carboxypeptidase Inhibitor* , 2004, Journal of Biological Chemistry.
[53] E. Shaw,et al. [2] Titration of trypsin, plasmin, and thrombin with p-nitrophenyl p′-guanidinobenzoate HCl☆ , 1970 .
[54] R. Huber,et al. Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Crystal structure determination and stereochemistry of the contact region. , 1973, Journal of molecular biology.
[55] Bruce A. Johnson,et al. NMR View: A computer program for the visualization and analysis of NMR data , 1994, Journal of biomolecular NMR.
[56] T. Creighton,et al. The disulfide folding pathway of BPTI. , 1992, Science.
[57] P. S. Kim,et al. Contribution of individual side-chains to the stability of BPTI examined by alanine-scanning mutagenesis. , 1995, Journal of molecular biology.
[58] J. Cairns. Inhibitors of mast cell tryptase beta as therapeutics for the treatment of asthma and inflammatory disorders. , 2005, Pulmonary pharmacology & therapeutics.
[59] J. Thornton,et al. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.
[60] E. Querol,et al. Analysis of the effect of potato carboxypeptidase inhibitor pro-sequence on the folding of the mature protein. , 2003, European journal of biochemistry.
[61] F. Avilés,et al. Folding of small disulfide-rich proteins: clarifying the puzzle. , 2006, Trends in biochemical sciences.
[62] D. Goldenberg,et al. Functional and structural roles of the Cys14-Cys38 disulfide of bovine pancreatic trypsin inhibitor. , 2008, Journal of molecular biology.
[63] M. Czisch,et al. Structure of leech derived tryptase inhibitor (LDTI‐C) in solution , 1994, FEBS letters.
[64] S. Ventura,et al. Protease inhibitors as models for the study of oxidative folding. , 2011, Antioxidants & redox signaling.
[65] Jui-Yoa Chang. Denatured States of Tick Anticoagulant Peptide , 1999, The Journal of Biological Chemistry.